Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Everett E. Vokes

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Vokes, Everett E.

Item TypeName
Concept Head and Neck Neoplasms
Academic Article Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Academic Article Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Academic Article Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
Academic Article Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
Academic Article Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Academic Article Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review.
Academic Article Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.
Academic Article Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Academic Article Is patient travel distance associated with survival on phase II clinical trials in oncology?
Academic Article Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients.
Academic Article Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
Academic Article Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Academic Article Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Academic Article Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
Academic Article A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.
Academic Article Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
Academic Article Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Academic Article Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
Academic Article A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
Academic Article Aspiration in chemoradiated patients with head and neck cancer.
Academic Article The expanding role of systemic therapy in head and neck cancer.
Academic Article The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Academic Article Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Academic Article Concurrent chemoradiotherapy for head and neck cancer.
Academic Article Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.
Academic Article Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Academic Article Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.
Academic Article Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers.
Academic Article High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Academic Article Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
Academic Article Neck dissection planning based on postchemoradiation computed tomography in patients with head and neck cancer.
Academic Article Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
Academic Article Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.
Academic Article Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Academic Article Head and neck cancer in 2010: Maximizing survival and minimizing toxicity.
Academic Article A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Academic Article Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Academic Article Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
Academic Article Free-flap reconstruction in the doubly irradiated patient population.
Academic Article Predictors of competing mortality in advanced head and neck cancer.
Academic Article Planned post-chemoradiation neck dissection: significance of radiation dose.
Academic Article A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.
Academic Article Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Academic Article Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.
Academic Article Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.
Academic Article Radiotherapy: Accelerated radiotherapy for HNSCC in developing countries.
Academic Article Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck.
Academic Article Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation.
Academic Article Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Academic Article A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.
Academic Article Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
Academic Article Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers.
Academic Article The chemoradiation paradigm in head and neck cancer.
Academic Article Expanding role of the medical oncologist in the management of head and neck cancer.
Academic Article Chemoradiotherapy for locally advanced head and neck cancer.
Academic Article Somatic acquisition and signaling of TGFBR1*6A in cancer.
Academic Article Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Academic Article Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers.
Academic Article Current treatments and promising investigations in a multidisciplinary setting.
Academic Article Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Academic Article Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Academic Article Introduction: head and neck cancer.
Academic Article Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.
Academic Article Curative treatment for advanced head and neck cancer in the community: has the time come?
Academic Article Combining radiotherapy with systemic therapies.
Academic Article Induction chemotherapy: to use or not to use? That is the question.
Academic Article Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
Academic Article Induction chemotherapy for head and neck cancer: recent data.
Academic Article A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeā„¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Academic Article EGFR-directed treatments in SCCHN.
Academic Article The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium.
Academic Article Cetuximab in cancers of the lung and head & neck.
Academic Article Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].
Academic Article Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Academic Article Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.
Academic Article Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.
Academic Article Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.
Academic Article DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
Academic Article Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
Academic Article Race and competing mortality in advanced head and neck cancer.
Academic Article Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.
Academic Article Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer.
Academic Article EGFR-based bioradiotherapy in SCCHN.
Academic Article Reply to s. Chakraborty et al.
Academic Article Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab.
Academic Article HPV-Associated Head and Neck Cancer.
Academic Article Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
Academic Article Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
Academic Article Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.
Academic Article Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Academic Article Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
Academic Article CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
Academic Article Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancer.
Academic Article Management of Early Head and Neck Cancer in Elderly Patients.
Academic Article Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use.
Academic Article Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
Academic Article Palbociclib: a new partner for cetuximab?
Academic Article Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains?
Academic Article A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer.
Academic Article Prolonging Life, but at What Price?
Academic Article A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Academic Article A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
Academic Article Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.
Academic Article Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Academic Article Is This the Dawn of Precision Oncology in Head and Neck Cancer?
Academic Article Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.

Search Criteria
  • Head and Neck Neoplasms